Literature DB >> 23913960

Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling.

Yang Zhou1, Min-Jong Kang, Babal Kant Jha, Robert H Silverman, Chun Geun Lee, Jack A Elias.   

Abstract

Interactions between cigarette smoke (CS) exposure and viral infection play an important role(s) in the pathogenesis of chronic obstructive pulmonary disease and a variety of other disorders. A variety of lines of evidence suggest that this interaction induces exaggerated inflammatory, cytokine, and tissue remodeling responses. We hypothesized that the 2'-5' oligoadenylate synthetase (OAS)/RNase L system, an innate immune antiviral pathway, plays an important role in the pathogenesis of these exaggerated responses. To test this hypothesis, we characterize the activation of 2'-5' OAS in lungs from mice exposed to CS and viral pathogen-associated molecular patterns (PAMPs)/live virus, alone and in combination. We also evaluated the inflammatory and remodeling responses induced by CS and virus/viral PAMPs in lungs from RNase L null and wild-type mice. These studies demonstrate that CS and viral PAMPs/live virus interact in a synergistic manner to stimulate the production of select OAS moieties. They also demonstrate that RNase L plays a critical role in the pathogenesis of the exaggerated inflammatory, fibrotic, emphysematous, apoptotic, TGF-β1, and type I IFN responses induced by CS plus virus/viral PAMP in combination. These studies demonstrate that CS is an important regulator of antiviral innate immunity, highlight novel roles of RNase L in CS plus virus induced inflammation, tissue remodeling, apoptosis, and cytokine elaboration and highlight pathways that may be operative in chronic obstructive pulmonary disease and mechanistically related disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23913960      PMCID: PMC3750064          DOI: 10.4049/jimmunol.1300082

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

Authors:  J Chebath; P Benech; M Revel; M Vigneron
Journal:  Nature       Date:  1987 Dec 10-16       Impact factor: 49.962

2.  Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells.

Authors:  J Chebath; P Benech; A Hovanessian; J Galabru; M Revel
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

3.  Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells.

Authors:  A G Hovanessian; J Svab; I Marié; N Robert; S Chamaret; A G Laurent
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

4.  Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression.

Authors:  G Rysiecki; D R Gewert; B R Williams
Journal:  J Interferon Res       Date:  1989-12

5.  Smoking and epidemic influenza-like illness in female military recruits: a brief survey.

Authors:  J D Kark; M Lebiush
Journal:  Am J Public Health       Date:  1981-05       Impact factor: 9.308

6.  2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Authors:  A P Rice; W K Roberts; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.

Authors:  D H Wreschner; T C James; R H Silverman; I M Kerr
Journal:  Nucleic Acids Res       Date:  1981-04-10       Impact factor: 16.971

8.  Smoking, alcohol consumption, and susceptibility to the common cold.

Authors:  S Cohen; D A Tyrrell; M A Russell; M J Jarvis; A P Smith
Journal:  Am J Public Health       Date:  1993-09       Impact factor: 9.308

9.  rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells.

Authors:  R H Silverman; J J Skehel; T C James; D H Wreschner; I M Kerr
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

10.  Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men.

Authors:  J D Kark; M Lebiush; L Rannon
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

View more
  10 in total

1.  Regulation of Retinoic Acid Receptor Beta by Interleukin-15 in the Lung during Cigarette Smoking and Influenza Virus Infection.

Authors:  Jianmiao Wang; Wei Liu; Chad Marion; Rajvir Singh; Nathaniel Andrews; Chun Geun Lee; Jack A Elias; Charles S Dela Cruz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

2.  RNase L targets distinct sites in influenza A virus RNAs.

Authors:  Daphne A Cooper; Shuvojit Banerjee; Arindam Chakrabarti; Adolfo García-Sastre; Jay R Hesselberth; Robert H Silverman; David J Barton
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

3.  Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.

Authors:  L Dillon Birdwell; Zachary B Zalinger; Yize Li; Patrick W Wright; Ruth Elliott; Kristine M Rose; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

Review 4.  Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases.

Authors:  Un Yung Choi; Ji-Seon Kang; Yune Sahng Hwang; Young-Joon Kim
Journal:  Exp Mol Med       Date:  2015-03-06       Impact factor: 8.718

5.  Influenza A virus-dependent remodeling of pulmonary clock function in a mouse model of COPD.

Authors:  Isaac K Sundar; Tanveer Ahmad; Hongwei Yao; Jae-woong Hwang; Janice Gerloff; B Paige Lawrence; Michael T Sellix; Irfan Rahman
Journal:  Sci Rep       Date:  2015-04-29       Impact factor: 4.379

6.  Radiotherapy-Associated Long-term Modification of Expression of the Inflammatory Biomarker Genes ARG1, BCL2L1, and MYC.

Authors:  Grainne Manning; Aleš Tichý; Igor Sirák; Christophe Badie
Journal:  Front Immunol       Date:  2017-04-10       Impact factor: 7.561

7.  Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice.

Authors:  Robert F Foronjy; Abdoulaye J Dabo; Clifford C Taggart; Sinead Weldon; Patrick Geraghty
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis.

Authors:  Bing Ma; Erica L Herzog; Meagan Moore; Chang-Min Lee; Sung Hun Na; Chun Geun Lee; Jack A Elias
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

9.  Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses.

Authors:  Yohannes A Mebratu; Kevin R Smith; Getahun E Agga; Yohannes Tesfaigzi
Journal:  Respir Res       Date:  2016-07-01

Review 10.  Epithelial Barrier Dysfunction in Chronic Respiratory Diseases.

Authors:  François M Carlier; Charlotte de Fays; Charles Pilette
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.